ClinicalTrials.Veeva

Menu

Use of Hypotension Prediction Index to Reduce Intraoperative Hypotension in Major Thoracic Surgery

U

University Hospital Dubrava

Status

Completed

Conditions

Hypotension During Surgery

Treatments

Diagnostic Test: "Flotrac" guided hemodynamic optimization
Diagnostic Test: "Acumen IQ" guided hemodynamic optimization

Study type

Interventional

Funder types

Other

Identifiers

NCT05615168
2022/1807-03

Details and patient eligibility

About

Intraoperative hypotension is linked to increased incidence of perioperative adverse events such as myocardial and cerebrovascular infarction and acute kidney injury. Hypotension prediction index (HPI) is a novel machine learning guided algorithm which can predict hypotensive events using high fidelity analysis of pulse-wave contour. Goal of this trial is to determine whether use of HPI can reduce the number and duration of hypotensive events in patients undergoing major thoracic procedures.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients over 18 years of age
  • patients scheduled for elective major thoracic procedure (lung resection, pleurectomy or resection of the esophagus)
  • planned thoracotomy and intraoperative period of one lung ventilation
  • planned postoperative admission to the ICU

Exclusion criteria

  • persistent atrial fibrillation
  • structural heart defects (shunting or moderate to severe valvular anomalies)
  • preoperative serum hemoglobin levels < 120 g/L
  • severe heart failure classified as New York Heart Association (NYHA) grade IV

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups

AcumenIQ - HPI guided hemodynamic optimization
Experimental group
Description:
HPI guided hypotension prediction alarms... Interventions based on SVV (fluid), dp/dt (inotropes), EAdyn (pressors)
Treatment:
Diagnostic Test: "Acumen IQ" guided hemodynamic optimization
Flotrac - conventional GDT guided hemodynamic optimization
Active Comparator group
Description:
GDT guided hemodynamic optimization - MAP \> 65 mmHg, CI ≥ 2.4 l/min/m2, SVI ≥ 30 ml/beat/m2 and SVRI 1700-2400 dyn·s·cm-5/m2
Treatment:
Diagnostic Test: "Flotrac" guided hemodynamic optimization

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems